Compare JNJ & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JNJ | CRWD |
|---|---|---|
| Founded | 1886 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 174.3B |
| IPO Year | 2003 | 2019 |
| Metric | JNJ | CRWD |
|---|---|---|
| Price | $254.84 | $694.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 48 |
| Target Price | $238.20 | ★ $507.00 |
| AVG Volume (30 Days) | ★ 7.7M | 3.2M |
| Earning Date | 04-14-2026 | 06-02-2026 |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | ★ 90.50 | N/A |
| EPS | ★ 2.14 | 0.11 |
| Revenue | N/A | ★ $4,812,005,000.00 |
| Revenue This Year | $6.63 | $24.85 |
| Revenue Next Year | $7.43 | $21.40 |
| P/E Ratio | ★ $114.54 | $6,165.82 |
| Revenue Growth | N/A | ★ 21.71 |
| 52 Week Low | $151.52 | $342.72 |
| 52 Week High | $251.71 | $785.66 |
| Indicator | JNJ | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 72.20 | 59.70 |
| Support Level | $233.83 | $463.35 |
| Resistance Level | N/A | $785.66 |
| Average True Range (ATR) | 5.13 | 31.68 |
| MACD | 1.78 | -7.46 |
| Stochastic Oscillator | 99.24 | 81.82 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.